What is the level of liabilities of Sesen Bio this year?
Sesen Bio has a debt balance of 30.98 M USD this year.
Sesen Bio Liabilities 2024
Sesen Bio Liabilities
30.98 M USD
Ticker
SESN
ISIN
US8177631053
WKN
A2JL47
In 2024, Sesen Bio's total liabilities amounted to 30.98 M USD, a -55.12% difference from the 69.04 M USD total liabilities in the previous year.
Sesen Bio Aktienanalyse
What does Sesen Bio do?
Sesen Bio Inc. is a biotechnology company focused on developing advanced therapeutics for the treatment of cancer and other challenging diseases. The company was founded in 2010 in Cambridge, Massachusetts, and has since expanded its research and development efforts to develop a range of therapies based on its innovative technologies and approaches. The goal of Sesen Bio is to develop groundbreaking drugs and therapies that are both safe and effective, helping patients successfully fight their illness. The company's focus is on unlocking new treatment possibilities through its proprietary platforms, including its antibody-drug conjugate (ADC) technology, on which all drug candidates are based. Sesen Bio has three main divisions: cancer treatment, therapy development, and partnership program. The cancer treatment division focuses on clinical trials and product marketing. This is where the first approved drug, Vicinium, is mentioned. Vicinium is an ADC consisting of a monoclonal antibody against prostate-specific membrane antigen (PSMA). It is indicated for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The therapy development division is involved in creating drug candidates and advancing their development through clinical trials. The partnership program allows Sesen Bio to license and commercialize its technologies and platforms by partnering with other biotechnology companies and pharmaceutical companies. The company has made significant progress in the development of therapeutics in recent years. The first approved drug, Vicinium, has propelled the company forward. The company is conducting clinical trials on other drug candidates to evaluate their efficacy and safety. Additionally, the company has a pipeline of new products in various stages of development, including NG-348, a novel ADC targeting the epidermal growth factor receptor (EGFR) that can be used in the treatment of solid tumors in various organs. Sesen Bio aims to further expand its innovative technologies in the field of cancer therapy and expand its offering of groundbreaking therapeutics. The company works closely with its partners and customers to develop customized treatment solutions and ensure high patient satisfaction. With its dedicated research and development department, well-established partnerships, and ability to make groundbreaking technologies widely available, Sesen Bio is on track to become a leading company in the field of cancer therapy. Overall, Sesen Bio is an innovative biotechnology company dedicated to developing therapeutics that improve the lives of patients with cancer and other serious diseases. Through its proprietary technologies and platforms, dedicated research and development departments, and well-established partnerships, the company has established itself as a key player in the field of cancer therapy. Sesen Bio is a company with a vision and a mission that permeate everything it does, namely saving and improving lives. Sesen Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Sesen Bio's Liabilities
Sesen Bio's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sesen Bio's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Sesen Bio's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Sesen Bio's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Sesen Bio’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Sesen Bio stock
What were the liabilities of Sesen Bio compared to the previous year?
The liabilities of Sesen Bio have increased by -55.12% dropped compared to the previous year.
What are the consequences of high debt for investors of Sesen Bio?
High liabilities can pose a risk for investors of Sesen Bio, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Sesen Bio?
Low liabilities mean that Sesen Bio has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Sesen Bio affect the company?
An increase in liabilities of Sesen Bio can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Sesen Bio affect the company?
A decrease in the liabilities of Sesen Bio can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Sesen Bio?
Some factors that can influence the liabilities of Sesen Bio include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Sesen Bio so important for investors?
The liabilities of Sesen Bio are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Sesen Bio take to modify the liabilities?
To change its liabilities, Sesen Bio can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Sesen Bio pay?
Over the past 12 months, Sesen Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sesen Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of Sesen Bio?
The current dividend yield of Sesen Bio is .
When does Sesen Bio pay dividends?
Sesen Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sesen Bio?
Sesen Bio paid dividends every year for the past 0 years.
What is the dividend of Sesen Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sesen Bio located?
Sesen Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sesen Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sesen Bio from 8/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2024.
When did Sesen Bio pay the last dividend?
The last dividend was paid out on 8/1/2024.
What was the dividend of Sesen Bio in the year 2023?
In the year 2023, Sesen Bio distributed 0 USD as dividends.
In which currency does Sesen Bio pay out the dividend?
The dividends of Sesen Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sesen Bio stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Sesen Bio
Our stock analysis for Sesen Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sesen Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
